Jun Pu

447 total citations
39 papers, 295 citations indexed

About

Jun Pu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jun Pu has authored 39 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 18 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jun Pu's work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (12 papers) and Ferroptosis and cancer prognosis (10 papers). Jun Pu is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (12 papers) and Ferroptosis and cancer prognosis (10 papers). Jun Pu collaborates with scholars based in China, United States and Egypt. Jun Pu's co-authors include Xiulin Jiang, Yulin Shi, Yongbin Chen, Zhi Nie, Cuiping Yang, Kun Liu, Liping Jiang, Yixiao Yuan, Xi Chen and Qiushuo Shen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Jun Pu

36 papers receiving 290 citations

Peers

Jun Pu

ONCOL

PRM

IMMUN

Thomas Jackson United Kingdom

Monika Rak Poland

Brijesh Kumar United States

Graeme Benstead-Hume United Kingdom

Majid Motovali-Bashi Iran

Petr Chlapek Czechia

Lanya Li China

Dimitris Karagiannis United States

Mushtaq Ahmad Nengroo India

Evangelia K. Papachristou United Kingdom

Thomas Jackson United Kingdom

Jun Pu

255 ×1.4

82 ×0.9

77 ×1.2

ONCOL

45 ×1.0

PRM

28 ×0.9

IMMUN

Citations per year, relative to Jun Pu Jun Pu (= 1×) peers Thomas Jackson

Countries citing papers authored by Jun Pu

Since Specialization

Citations

This map shows the geographic impact of Jun Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Pu more than expected).

Fields of papers citing papers by Jun Pu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Pu. The network helps show where Jun Pu may publish in the future.

Co-authorship network of co-authors of Jun Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Pu. A scholar is included among the top collaborators of Jun Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Pu. Jun Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Zhi, Yizheng Yao, Xi Chen, et al.. (2025). Cross-species tropism of AAV.CPP.16 in the respiratory tract and its gene therapies against pulmonary fibrosis and viral infection. Cell Reports Medicine. 6(6). 102144–102144. 1 indexed citations

Yuan, Yixiao, Fan Zhou, Xiaobing Huang, et al.. (2025). RNA m5C modification: from physiology to pathology and its biological significance. Frontiers in Immunology. 16. 1599305–1599305. 8 indexed citations

Chen, Xinyuan, Yue Ma, Ruowen Wang, et al.. (2024). Aptamer BT200 is protective against myocardial ischemia-reperfusion injury in mice. Journal of Thrombosis and Haemostasis. 23(1). 222–234. 2 indexed citations

Pu, Jun, Ruoying Yu, Qiuxiang Ou, et al.. (2023). Pan‐cancer molecular analysis of EGFR large fragment deletion in the Asian population. Cancer Medicine. 12(7). 8083–8088. 2 indexed citations

Shi, Yulin, Zhi Nie, Li Yao, et al.. (2023). Sertindole inhibits autophagic flux and glioma progression. SHILAP Revista de lepidopterología. 2(2). 1 indexed citations

Xu, Haitao, et al.. (2023). CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma. OncoTargets and Therapy. Volume 16. 819–837. 2 indexed citations

Jiang, Xiulin, et al.. (2022). Identification and Validation of lncRNA-AC087588.2 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator. Frontiers in Molecular Biosciences. 9. 923584–923584.

Liu, Kun, Liping Jiang, Yulin Shi, et al.. (2022). Hypoxia-induced GLT8D1 promotes glioma stem cell maintenance by inhibiting CD133 degradation through N-linked glycosylation. Cell Death and Differentiation. 29(9). 1834–1849. 43 indexed citations

Wang, Kaiwen, Qingyuan Liu, Jun Pu, et al.. (2022). Early-start antiplatelet therapy after operation in patients with spontaneous intracerebral hemorrhage and high risk of ischemic events (E-start): Protocol for a multi-centered, prospective, open-label, blinded endpoint randomized controlled trial. Frontiers in Aging Neuroscience. 14. 1020224–1020224.

10.

Jiang, Xiulin, Yulin Shi, Xi Chen, et al.. (2022). The N6-Methylandenosine-Related Gene BIRC5 as a Prognostic Biomarker Correlated With Cell Migration and Immune Cell Infiltrates in Low Grade Glioma. Frontiers in Molecular Biosciences. 9. 773662–773662. 5 indexed citations

11.

Liu, Wei, et al.. (2022). Genetic association of ANRIL with susceptibility to Ischemic stroke: A comprehensive meta-analysis. PLoS ONE. 17(6). e0263459–e0263459. 4 indexed citations

12.

Jiang, Xiulin, Yulin Shi, Xi Chen, et al.. (2022). NCAPG as a Novel Prognostic Biomarker in Glioma. Frontiers in Oncology. 12. 831438–831438. 10 indexed citations

13.

Pu, Jun, Zhe Liu, Jing Wei, et al.. (2021). HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells. Signal Transduction and Targeted Therapy. 6(1). 399–399. 21 indexed citations

14.

Zhang, Shudong, et al.. (2021). Depletion of CIP2A inhibits the proliferation, migration, invasion and epithelial-mesenchymal transition of glioma cells. Brain Research Bulletin. 173. 14–21. 2 indexed citations

15.

Liu, Kun, Jun Pu, Zhi Nie, et al.. (2021). Ivacaftor Inhibits Glioblastoma Stem Cell Maintenance and Tumor Progression. Frontiers in Cell and Developmental Biology. 9. 678209–678209. 16 indexed citations

16.

Li, Xinru, Jun Pu, Jiaxin Liu, et al.. (2018). The prognostic value of DAPK1 hypermethylation in gliomas: A site-specific analysis. Pathology - Research and Practice. 214(7). 940–948. 4 indexed citations

17.

Wu, Jing, Xiaolan Yang, Deqiang Wang, et al.. (2016). A Numerical Approach for Kinetic Analysis of the Nonexponential Thermoinactivation Process of Uricase. The Protein Journal. 35(4). 318–329. 4 indexed citations

18.

Yuan, Mei, Xiaolan Yang, Yuwei Li, et al.. (2016). Facile Alkaline Lysis of Escherichia coli Cells in High-Throughput Mode for Screening Enzyme Mutants: Arylsulfatase as an Example. Applied Biochemistry and Biotechnology. 179(4). 545–557. 6 indexed citations

19.

Li, Yuanli, Xiaolan Yang, Yanling Xie, et al.. (2014). Selective and sensitive homogenous assay of serum albumin with 1-anilinonaphthalene-8-sulphonate as a biosensor. Analytica Chimica Acta. 829. 60–67. 7 indexed citations

20.

Peng, Fang, Xian‐Chun Zeng, Xiaohua He, et al.. (2002). Molecular cloning and functional expression of a gene encoding an antiarrhythmia peptide derived from the scorpion toxin. European Journal of Biochemistry. 269(18). 4468–4475. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact